glp-1 and gip/glp-1 medications It's important to study the difference in medications. Our analysis found tirzepatide is associated with a lower risk of serious heart kidney complications compared to dulaglutide in adults with Type GLP1 agonists: current and future
Description
Brain-Gut Connection Increases satiety and slows gastric emptying, reducing caloric intake

GLP-1 medications have had a meteoric rise

Weight loss Available in NZ = Liraglutide high dose (Saxenda, daily injection) Self-funding needed ($500-600/month) Not available in NZ = Semaglutide (Ozempic, Wegovy) or Tirzepatide (Mounjaro), as of May 2023 Side effects, particularly upper gastrointestinal, are common with GLP-1 agonist initiation
Medications are compounded by a licensed pharmacy and titrated gradually to improve tolerance

"Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials." Clinical Pharmacokinetics

We need to employ things early on
